Jamshed Bomanji
University College London Hospitals NHS Foundation Trust
Correction for attenuationInternal medicineRadiologyPET-CTSurgeryPathologyOncologyAttenuationMedical physicsPositron emission tomographyOsteosarcomaProstate cancerNuclear medicineRadionuclide therapyIn patientFdg pet ctRadiation therapyColorectal cancerClinical trialMedicine
104Publications
12H-index
571Citations
Publications 102
Newest
#1Sarah KiffH-Index: 2
Last. Pratik ShahH-Index: 13
view all 12 authors...
#1Ralph McCreadyH-Index: 1
Last. Jamshed BomanjiH-Index: 12
view all 3 authors...
© The Editor(s) (if applicable) and The Author(s) 2016. The British Nuclear Medicine Society celebrates its 50th Anniversary with this booklet, which reflects the research of many of the pioneers in the use of radionuclides for the diagnosis and therapy of human disease. Since 1949 there have been remarkable advances in radionuclide techniques and imaging equipment: from the first devices "home-made" in the many physics departments throughout the UK, to the sophisticated multimodality imagers no...
Source
#1Serena ChiacchioH-Index: 8
Last. Jamshed Bomanji (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
view all 5 authors...
Source
#1Shaunak Navalkissoor (Royal Free London NHS Foundation Trust)H-Index: 11
#2Thomas Wagner (Royal Free London NHS Foundation Trust)H-Index: 10
Last. Jamshed Bomanji (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
view all 5 authors...
18F-FDG PET is a frequently used imaging modality in the evaluation of cancer patients. A high-quality study performed 18F-FDG PET study should be repeatable (same result produced if imaged on the same system) and reproducible (similar result if imaged at different sites). An essential component of this is adequate patient preparation to ensure study reproducibility and technical quality. Rigorous instructions should be followed regarding patient procedure. In addition, adequate referral informa...
Source
#1Mark N. Gaze (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 28
#2Jennifer E. Gains (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 9
Last. Jamshed Bomanji (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
view all 3 authors...
Molecular radiotherapy is the use of systemically administered radiopharmaceuticals for the treatment of cancer. Molecular radiotherapy in children is most commonly indicated for thyroid cancer, neuroblastoma and other neuroendocrine tumours. The treatments most often administered are 131I-sodium iodide, 131I-meta-iodobenzylguanidin and radiolabelled peptides such as 177Lu-Lutetium DOTATATE.
1 CitationsSource
#1Marco Schito (Critical Path Institute)H-Index: 39
#2Giovanni Battista Migliori (WHO: World Health Organization)H-Index: 87
Last. Alimuddin Zumla (NIHR: National Institute for Health Research)H-Index: 109
view all 16 authors...
Despite concerted efforts over the past 2 decades at developing new diagnostics, drugs, and vaccines with expanding pipelines, tuberculosis remains a global emergency. Several novel diagnostic technologies show promise of better point-of-care rapid tests for tuberculosis including nucleic acid-based amplification tests, imaging, and breath analysis of volatile organic compounds. Advances in new and repurposed drugs for use in multidrug-resistant (MDR) or extensively drug-resistant (XDR) tubercul...
34 CitationsSource
#1Eva Tsouana (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 1
#2Sara Stoneham (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
Last. Ananth Shankar (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 14
view all 9 authors...
The efficacy of hybrid 18F-Fluroethyl-Choline (FEC) positron emission tomography (PET)/magnetic resonance imaging (MRI) was investigated as an imaging modality for diagnosis and assessment of treatment response and remission status in four patients with proven or suspected intracranial non-germinomatous germ cell tumours (NGGCT). In two patients faint or absent choline avidity correlated with negative histology, whereas in other two patients, persistent choline avidity in the residual mass was s...
9 CitationsSource
#1Francesco Fraioli (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 23
#2Nicholas Screaton (Papworth Hospital)H-Index: 28
Last. Ashley M. Groves (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 48
view all 13 authors...
Purpose To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer.
28 CitationsSource
#1Jillian Maclean (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 3
#2Matthew D. Aldridge (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 5
Last. Naomi Fersht (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
view all 5 authors...
Purpose There are limited treatment options for progressive atypical pituitary adenomas and carcinomas. Peptide receptor radionuclide therapy that targets somatostatin receptors has recently been proposed as a potential treatment option. The theoretical rationale for efficacy is elegant but evaluation of outcomes in the first patients treated for this indication is required to assess whether further study is warranted.
38 CitationsSource
#1Rakesh SajjanH-Index: 3
#2Jamshed BomanjiH-Index: 12
Source